Samantha Shawn Marsh, PMHNP-BC

NPI: 1053743286
Total Payments
$534,069
2024 Payments
$162,567
Companies
9
Transactions
1,112

Payment Breakdown by Category

Other$384,958 (72.1%)
Consulting$65,468 (12.3%)
Travel$64,107 (12.0%)
Food & Beverage$19,446 (3.6%)
Education$91.05 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $384,958 296 72.1%
Consulting Fee $65,468 54 12.3%
Travel and Lodging $64,107 313 12.0%
Food and Beverage $19,446 445 3.6%
Education $91.05 4 0.0%

Top Paying Companies

Company Total Records Latest Year
ABBVIE INC. $399,251 775 $0 (2024)
Axsome Therapeutics, Inc. $75,926 134 $0 (2024)
Corium, LLC $36,675 119 $0 (2024)
Otsuka America Pharmaceutical, Inc. $20,297 48 $0 (2023)
Takeda Pharmaceuticals U.S.A., Inc. $826.34 27 $0 (2022)
Allergan, Inc. $825.00 1 $0 (2021)
Lundbeck LLC $124.84 6 $0 (2022)
Janssen Pharmaceuticals, Inc $118.44 1 $0 (2023)
Alfasigma USA, Inc. $25.68 1 $0 (2021)

Payment History by Year

Year Amount Transactions Top Company
2024 $162,567 300 ABBVIE INC. ($126,188)
2023 $226,181 449 ABBVIE INC. ($144,492)
2022 $79,456 172 ABBVIE INC. ($71,842)
2021 $65,865 191 AbbVie Inc. ($56,729)

All Payment Transactions

1,112 individual payment records from CMS Open Payments — Page 1 of 45

Date Company Product Nature Form Amount Type
12/16/2024 Axsome Therapeutics, Inc. Auvelity (Drug) Consulting Fee Cash or cash equivalent $650.00 General
Category: Psychology/Psychiatric
12/12/2024 Axsome Therapeutics, Inc. Auvelity (Drug) Consulting Fee Cash or cash equivalent $650.00 General
Category: Psychology/Psychiatric
11/13/2024 ABBVIE INC. VRAYLAR (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $1,500.00 General
Category: NEUROSCIENCE
11/12/2024 Axsome Therapeutics, Inc. Auvelity (Drug) Consulting Fee Cash or cash equivalent $650.00 General
Category: Psychology/Psychiatric
11/07/2024 Axsome Therapeutics, Inc. Auvelity (Drug) Consulting Fee Cash or cash equivalent $650.00 General
Category: Psychology/Psychiatric
11/05/2024 ABBVIE INC. VRAYLAR (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $2,100.00 General
Category: NEUROSCIENCE
11/05/2024 ABBVIE INC. VRAYLAR (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $1,500.00 General
Category: NEUROSCIENCE
11/05/2024 ABBVIE INC. VRAYLAR (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $1,500.00 General
Category: NEUROSCIENCE
11/05/2024 ABBVIE INC. VRAYLAR (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $1,500.00 General
Category: NEUROSCIENCE
11/05/2024 Axsome Therapeutics, Inc. Auvelity (Drug) Consulting Fee Cash or cash equivalent $650.00 General
Category: Psychology/Psychiatric
11/05/2024 Axsome Therapeutics, Inc. Auvelity (Drug) Consulting Fee Cash or cash equivalent $650.00 General
Category: Psychology/Psychiatric
10/29/2024 ABBVIE INC. VRAYLAR (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $2,100.00 General
Category: NEUROSCIENCE
10/21/2024 ABBVIE INC. VRAYLAR (Drug) Travel and Lodging In-kind items and services $85.00 General
Category: NEUROSCIENCE
10/18/2024 ABBVIE INC. VRAYLAR (Drug) Travel and Lodging In-kind items and services $303.95 General
Category: NEUROSCIENCE
10/18/2024 ABBVIE INC. VRAYLAR (Drug) Travel and Lodging In-kind items and services $257.97 General
Category: NEUROSCIENCE
10/17/2024 ABBVIE INC. VRAYLAR (Drug) Travel and Lodging In-kind items and services $309.36 General
Category: NEUROSCIENCE
10/17/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $81.54 General
Category: NEUROSCIENCE
10/17/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $30.91 General
Category: NEUROSCIENCE
10/17/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $27.88 General
Category: NEUROSCIENCE
10/17/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $20.75 General
Category: NEUROSCIENCE
10/17/2024 ABBVIE INC. VRAYLAR (Drug) Travel and Lodging In-kind items and services $16.08 General
Category: NEUROSCIENCE
10/16/2024 ABBVIE INC. VRAYLAR (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $2,100.00 General
Category: NEUROSCIENCE
10/16/2024 ABBVIE INC. VRAYLAR (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $1,500.00 General
Category: NEUROSCIENCE
10/16/2024 ABBVIE INC. VRAYLAR (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $1,500.00 General
Category: NEUROSCIENCE
10/16/2024 ABBVIE INC. VRAYLAR (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $1,500.00 General
Category: NEUROSCIENCE

About Samantha Shawn Marsh, PMHNP-BC

Samantha Shawn Marsh, PMHNP-BC is a Psychiatric/Mental Health healthcare provider based in Westerly, Rhode Island. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/30/2013. The National Provider Identifier (NPI) number assigned to this provider is 1053743286.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Samantha Shawn Marsh, PMHNP-BC has received a total of $534,069 in payments from pharmaceutical and medical device companies, with $162,567 received in 2024. These payments were reported across 1,112 transactions from 9 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($384,958).

Practice Information

  • Specialty Psychiatric/Mental Health
  • Other Specialties Psychiatric/Mental Health
  • Location Westerly, RI
  • Active Since 07/30/2013
  • Last Updated 06/24/2023
  • Taxonomy Code 363LP0808X
  • Entity Type Individual
  • Practice Solo Practitioner
  • NPI Number 1053743286

Products in Payments

  • VRAYLAR (Drug) $400,069
  • Auvelity (Drug) $75,926
  • Azstarys (Drug) $35,166
  • REXULTI (Drug) $20,422
  • AZSTARYS (Drug) $1,419
  • TRINTELLIX (Drug) $751.10
  • SPRAVATO (Drug) $118.44
  • VYVANSE (Drug) $69.65
  • VIIBRYD (Drug) $6.96

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Psychiatric/Mental Health Doctors in Westerly